a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

被引：1
|
作者：
Maddocks, Kami J. [1 ]
Cohen, Jonathon B. [2 ]
Huang, Ying [1 ]
Christian, Beth A. [3 ,4 ]
Benson, Don M. [1 ]
Jones, Jeffrey [1 ]
Flowers, Christopher [5 ]
Heffner, Leonard T. [6 ]
Jenkins, Cynthia [7 ]
Sexton, Jennfer [7 ]
Neal, Alison [7 ]
Kives, Melissa [2 ]
Blum, Kristie A. [3 ,4 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[3] James Canc Hosp, Dept Internal Med, Div Hematol, Columbus, OH USA
[4] Ohio State Univ, Solove Res Inst, Columbus, OH USA
[5] Emory Univ, Winship Canc Inst, Dept Bone Marrow & Stem Cell Transplantat, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA
[7] Ohio State Univ, Columbus, OH USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1776.1776
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1776
引用
收藏
页数：5
相关论文
共 50 条
  • [1] A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)
    Maddocks, Kami J.
    Cohen, Jonathon B.
    Christian, Beth A.
    Benson, Don M.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
  • [2] A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma
    Bond, David A.
    Huang, Ying
    Christian, Beth A.
    Jaglowski, Samantha
    Benson, Don
    Alinari, Lapo
    Baiocchi, Robert A.
    Cohen, Jonathon B.
    Blum, Kristie A.
    Maddocks, Kami J.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1750 - 1753
  • [3] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [4] A pilot study of combined therapy with rituximab (R) and epoch in refractory or relapsed diffuse large B-cell Non-Hodgkin's Lymphoma (NHL).
    Aung, S
    Krishnan, J
    Lessin, L
    Priebat, D
    Sharma, D
    Malkovska, V
    BLOOD, 1999, 94 (10) : 257B - 257B
  • [5] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Follicular Lymphoma
    Younes, Anas
    Salles, Gilles
    Bociek, R. Gregory
    Martinelli, Giovanni
    Caballero, Dolores
    Gonzalez Barca, Eva
    Mukherjee, Nabanita
    Williams, Lisa
    Herbst, Fabian
    Tavorath, Ranjana
    Kim, Won Seog
    BLOOD, 2014, 124 (21)
  • [7] Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Heyman, Benjamin
    Rizzieri, David
    Adams, David J.
    De Castro, Carlos
    Diehl, Louis
    Li, Zhiguo
    Moore, Joseph
    Beaven, Anne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 679 - 686
  • [8] A phase II study of BKM120 (buparlisib) in relapsed or refractory thymomas.
    Abu Zaid, Mohammad Issam
    Radovich, Milan
    Althouse, Sandra K.
    Liu, Hai
    Spittler, Aaron John
    Solzak, Jeffrey Peter
    Hancock, Bradley Allen
    Loehrer, Patrick J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Kuruvilla, John
    Smith, Sonali
    Porcu, Pierluigi
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [10] Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma
    Ansell, Stephen M.
    Witzig, Thomas E.
    Inwards, David J.
    Porrata, Luis F.
    Ythier, Arnaud
    Ferrande, Lee
    Nestorov, Ivan
    Devries, Todd
    Dillon, Stacey R.
    Hausman, Diana
    Novak, Anne J.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1105 - 1110
12345